DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

EnteroMedics (NASDAQ: ETRM)

0.96 -0.03 (-2.88%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ETRM $0.96 -2.88%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.99
Previous Close $0.99
Daily Range $0.96 - $0.99
52-Week Range $0.96 - $2.17
Market Cap $70.8M
P/E Ratio -2.53
Dividend (Yield) $0.00 (0.0%)
Volume 363,218
Average Daily Volume 699,663
Current FY EPS -$0.39




Healthcare IT

EnteroMedics (ETRM) Description

A development stage medical device company focused on the design and development of devices that use neuroblocking technology to treat obesity its associated co-morbidities and other gastrointestinal disorders. Website:

News & Commentary Rss Feed

Despite the CDC's Best Efforts, This Disease Just Hit Record Levels

The CDC is doing its best to curb this disease, but a recent Gallup survey suggests that more people have this disease than ever before!

Enteromedics: What Will 2015 Look Like?

Canaccord Genuity Remains Bullish on EnteroMedics Following Q4 Earnings

EnteroMedics' (ETRM) CEO Mark Knudson on Q4 2014 Results -- Earnings Call Transcript

Gallup Says Obesity Rates Climb Again - Can Anti-Obesity Companies Cash In?

Newly Approved Weight Loss Method Works by Tricking Your Brain

What's the best way to lose weight? One company thinks it's simple: don't get hungry.

Biotech Stock Mailbag: Arena Pharma, Agenus, EnteroMedics

Top-Rated Stock Picks and Most-Read Stories at Jan. 11-17, 2015

Forget Pills! Could This Device Put an End to Obesity in America?

We've witnessed three oral anti-obesity meds approved since mid-2012, but this newly approved device could be a game-changer.

Seeking Alpha's Biotech Weekly: Roche Takes Control, Shire's A Buyer, And More

See More ETRM News...

ETRM's Top Competitors

ETRM $0.96 (-2.88%)
Current stock: ETRM
$0.00 (0.00%)
Current stock:
MDT $77.38 (1.01%)
Current stock: MDT
COV $108.06 (0.00%)
Current stock: COV